These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23861301)

  • 1. Endogenous morphine-6-glucuronide (M6G) is present in the plasma of patients: validation of a specific anti-M6G antibody for clinical and basic research.
    Laux-Biehlmann A; Chung H; Mouheiche J; Vérièpe J; Delalande F; Lamshöft M; Welters ID; Soldevila S; Bazin H; Lamarque L; Van Dorsselaer A; Poisbeau P; Schneider F; Goumon Y; Garnero P
    Biofactors; 2014; 40(1):113-20. PubMed ID: 23861301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous assay of morphine, morphine-3-glucuronide and morphine-6-glucuronide in human plasma using normal-phase liquid chromatography-tandem mass spectrometry with a silica column and an aqueous organic mobile phase.
    Naidong W; Lee JW; Jiang X; Wehling M; Hulse JD; Lin PP
    J Chromatogr B Biomed Sci Appl; 1999 Dec; 735(2):255-69. PubMed ID: 10670739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A specific radioimmunoassay for the determination of morphine-6-glucuronide in human plasma.
    Chapman DJ; Cross MJ; Joel SP; Aherne GW
    Ann Clin Biochem; 1995 May; 32 ( Pt 3)():297-302. PubMed ID: 7632034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validated method for simultaneous determination of codeine, codeine-6-glucuronide, norcodeine, morphine, morphine-3-glucuronide and morphine-6-glucuronide in post-mortem blood, vitreous fluid, muscle, fat and brain tissue by LC-MS.
    Frost J; Løkken TN; Brede WR; Hegstad S; Nordrum IS; Slørdal L
    J Anal Toxicol; 2015 Apr; 39(3):203-12. PubMed ID: 25556373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a differential radioimmunoassay technique for the determination of morphine and morphine-6-glucuronide in human plasma.
    Chapman DJ; Joel SP; Aherne GW
    J Pharm Biomed Anal; 1994 Mar; 12(3):353-60. PubMed ID: 8031935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients.
    Ashby M; Fleming B; Wood M; Somogyi A
    J Pain Symptom Manage; 1997 Sep; 14(3):157-67. PubMed ID: 9291702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of blood sample preparation on measured levels of morphine and its major metabolites.
    Hoskin PJ; Alsayed-Omar O; Hanks GW; Johnston A; Turner P
    Ann Clin Biochem; 1989 Mar; 26 ( Pt 2)():182-4. PubMed ID: 2729862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children.
    Hain RD; Hardcastle A; Pinkerton CR; Aherne GW
    Br J Clin Pharmacol; 1999 Jul; 48(1):37-42. PubMed ID: 10383558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An automatic 96-well solid phase extraction and liquid chromatography-tandem mass spectrometry method for the analysis of morphine, morphine-3-glucuronide and morphine-6-glucuronide in human plasma.
    Shou WZ; Pelzer M; Addison T; Jiang X; Naidong W
    J Pharm Biomed Anal; 2002 Jan; 27(1-2):143-52. PubMed ID: 11682220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative gas chromatographic/mass spectrometric analysis of morphine glucuronides in human plasma by negative ion chemical ionization mass spectrometry.
    Leis HJ; Fauler G; Raspotnig G; Windischhofer W
    J Mass Spectrom; 2002 Apr; 37(4):395-400. PubMed ID: 11948846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capillary electrophoresis-mass spectrometry determination of morphine and its isobaric glucuronide metabolites.
    Isbell TA; Strickland EC; Hitchcock J; McIntire G; Colyer CL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Feb; 980():65-71. PubMed ID: 25589256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma morphine-3-glucuronide, morphine-6-glucuronide and morphine concentrations in patients receiving long-term epidural morphine.
    Schneider JJ; Ravenscroft PJ; Cavenagh JD; Brown AM; Bradley JP
    Br J Clin Pharmacol; 1992 Nov; 34(5):431-3. PubMed ID: 1467139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.
    Holthe M; Klepstad P; Zahlsen K; Borchgrevink PC; Hagen L; Dale O; Kaasa S; Krokan HE; Skorpen F
    Eur J Clin Pharmacol; 2002 Aug; 58(5):353-6. PubMed ID: 12185559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of morphine and morphine glucuronide levels and cytochrome P450 isoenzyme 2D6 genotype in codeine-related deaths.
    Frost J; Helland A; Nordrum IS; Slørdal L
    Forensic Sci Int; 2012 Jul; 220(1-3):6-11. PubMed ID: 22285504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive assay for the quantification of morphine and its active metabolites in human plasma and dried blood spots using high-performance liquid chromatography-tandem mass spectrometry.
    Clavijo CF; Hoffman KL; Thomas JJ; Carvalho B; Chu LF; Drover DR; Hammer GB; Christians U; Galinkin JL
    Anal Bioanal Chem; 2011 May; 400(3):715-28. PubMed ID: 21400080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine-3-glucuronide inhibits morphine induced, but enhances morphine-6-glucuronide induced locomotor activity in mice.
    Handal M; Ripel A; Aasmundstad T; Skurtveit S; Mørland J
    Pharmacol Biochem Behav; 2007 Mar; 86(3):576-86. PubMed ID: 17343905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
    Milne RW; Sloan PA; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
    Drug Metab Dispos; 1993; 21(6):1151-6. PubMed ID: 7905398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine, morphine-6-glucuronide and morphine-3-glucuronide concentrations in plasma and cerebrospinal fluid during long-term high-dose intrathecal morphine administration.
    Bigler D; Christensen BC; Eriksen J; Jensen HN
    Pain; 1990 Apr; 41(1):15-18. PubMed ID: 2352761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study.
    Klepstad P; Hilton P; Moen J; Kaasa S; Borchgrevink PC; Zahlsen K; Dale O
    BMC Clin Pharmacol; 2004 Oct; 4():7. PubMed ID: 15461818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the hydrolysis rates of morphine-3-glucuronide and morphine-6-glucuronide with acid and beta-glucuronidase.
    Romberg RW; Lee L
    J Anal Toxicol; 1995; 19(3):157-62. PubMed ID: 7564293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.